HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 23 October 2012

New NICE topics for ScHARR-TAG

The NICE technology appraisal group within HEDS – ScHARR-TAG – has had it’s next set of appraisals agreed with the NIHR.  These include two STAs and a non-NICE Short Report.  They are:

Degarelix (Firmagon, Ferring Pharmaceuticals) for the treatment of advanced hormone-dependent prostate cancer (STA)

Bevacizumab (Avastin, Roche) for the adjuvant treatment of triple negative early breast cancer (STA)

Sexual health of people with severe mental health illness (Short Report)